4//SEC Filing
CARE CAPITAL II LLC 4
Accession 0001104659-13-044386
CIK 0000786947other
Filed
May 22, 8:00 PM ET
Accepted
May 23, 5:45 PM ET
Size
14.6 KB
Accession
0001104659-13-044386
Insider Transaction Report
Form 4
CARE CAPITAL II LLC
10% Owner
Transactions
- Sale
Common Stock
2013-05-23$2.32/sh−62,000$143,840→ 5,828,815 total(indirect: See Footnote) - Sale
Common Stock
2013-05-22$2.30/sh−95,000$218,500→ 5,890,815 total(indirect: See Footnote) - Sale
Common Stock
2013-05-21$2.31/sh−95,000$219,450→ 5,985,815 total(indirect: See Footnote)
CARE CAPITAL INVESTMENTS II LP
10% Owner
Transactions
- Sale
Common Stock
2013-05-21$2.31/sh−95,000$219,450→ 5,985,815 total(indirect: See Footnote) - Sale
Common Stock
2013-05-23$2.32/sh−62,000$143,840→ 5,828,815 total(indirect: See Footnote) - Sale
Common Stock
2013-05-22$2.30/sh−95,000$218,500→ 5,890,815 total(indirect: See Footnote)
Transactions
- Sale
Common Stock
2013-05-21$2.31/sh−95,000$219,450→ 5,985,815 total(indirect: See Footnote) - Sale
Common Stock
2013-05-22$2.30/sh−95,000$218,500→ 5,890,815 total(indirect: See Footnote) - Sale
Common Stock
2013-05-23$2.32/sh−62,000$143,840→ 5,828,815 total(indirect: See Footnote)
Footnotes (9)
- [F1]The shares were sold as follows: 88,900 by Care Capital Investments II, LP and 6,100 by Care Capital Offshore Investments II, L.P.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.43 to $2.25, inclusive. The reporting person undertakes to provide to Acura Pharmaceuticals, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (5) and (8) to this Form 4.
- [F3]Consists of 5,601,543 shares held by Care Capital Investments II, LP and 384,272 shares held by Care Capital Offshore Investments II, L.P. Care Capital II, LLC is the general partner of Care Capital Investments II, LP and Care Capital Offshore Investments II, LP and as a result, Care Capital II, LLC has the ultimate power to vote or direct the vote and to dispose or direct the disposition of such shares. Care Capital II, LLC is managed by three or more members and accordingly none of the managing members is deemed to have voting or dispositive control over the securities.
- [F4]The shares were sold as follows: 88,900 by Care Capital Investments II, LP and 6,100 by Care Capital Offshore Investments II, L.P.
- [F5]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.36 to $2.26, inclusive.
- [F6]Consists of 5,512,643 shares held by Care Capital Investments II, LP and 378,172 shares held by Care Capital Offshore Investments II, L.P. Care Capital II, LLC is the general partner of Care Capital Investments II, LP and Care Capital Offshore Investments II, LP and as a result, Care Capital II, LLC has the ultimate power to vote or direct the vote and to dispose or direct the disposition of such shares. Care Capital II, LLC is managed by three or more members and accordingly none of the managing members is deemed to have voting or dispositive control over the securities.
- [F7]The shares were sold as follows: 58,019 by Care Capital Investments II, LP and 3,981 by Care Capital Offshore Investments II, L.P.
- [F8]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.38 to $2.25, inclusive.
- [F9]Consists of 5,454,624 shares held by Care Capital Investments II, LP and 374,191 shares held by Care Capital Offshore Investments II, L.P. Care Capital II, LLC is the general partner of Care Capital Investments II, LP and Care Capital Offshore Investments II, LP and as a result, Care Capital II, LLC has the ultimate power to vote or direct the vote and to dispose or direct the disposition of such shares. Care Capital II, LLC is managed by three or more members and accordingly none of the managing members is deemed to have voting or dispositive control over the securities.
Documents
Issuer
ACURA PHARMACEUTICALS, INC
CIK 0000786947
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001212648
Filing Metadata
- Form type
- 4
- Filed
- May 22, 8:00 PM ET
- Accepted
- May 23, 5:45 PM ET
- Size
- 14.6 KB